Caltagirone

Aktuelle Nachrichten

Schlagzeilen in der Originalsprache der Quelle.

• NKT (CPSE:NKT) Stock Sees Modest Fair Value Lift After More Balanced Analyst Views (öffnet in neuem Tab)

  03.10.2026

• Tecan Group Stock Sees Modest Fair Value Lift After Analyst Target Increases (öffnet in neuem Tab)

  03.10.2026

• Stocktwits Biotech Dealmaker — Novartis, Sanofi And Novo Sign Week’s Biggest Deals (öffnet in neuem Tab)

  03.10.2026

• Sector Update: Healthcare Stocks Steady Late Afternoon (öffnet in neuem Tab)

  02.10.2026

• Novartis wagers almost $8B on a Chinese biotech’s RNA drugs (öffnet in neuem Tab)

  02.10.2026

• Novartis licenses Abogen mRNA autoimmune drug in $7.8B deal (öffnet in neuem Tab)

  02.10.2026

• Agios' Growth Story Hinges on Mitapivat's Commercial Expansion (öffnet in neuem Tab)

  02.10.2026

• La ceramica di Caltagirone riceve il riconoscimento IGP (öffnet in neuem Tab)

  NewSicilia · 02.10.2026

• Novartis Signs RNA Therapy Licensing Deal With China’s Abogen Worth Up to $7.8 Billion (öffnet in neuem Tab)

  02.10.2026

• Abogen Announces Licensing and Option Agreement with Novartis to Advance mRNA-Encoded T-Cell Engager and other potential RNA programs (öffnet in neuem Tab)

  02.10.2026

• Azzurra Caltagirone: «Fare sistema e attrarre le nuove generazioni» (öffnet in neuem Tab)

  Il Messaggero · 01.10.2026

• Caltagirone, bufera sul Rendiconto 2025. Per Romeo "Bilancio finto" (öffnet in neuem Tab)

  La Gazzetta del Calatino · 01.10.2026

• Change in the holding of Suominen’s treasury shares (öffnet in neuem Tab)

  01.10.2026

• Deutsche Bank lists Top European Stock picks for the next twelve months (öffnet in neuem Tab)

  01.10.2026

• Suominen Corporation – Manager’s transaction: Charles Héaulmé (öffnet in neuem Tab)

  01.10.2026

• Rezolv secures up to $636m for 1.3GWp Dama Solar project in Romania (öffnet in neuem Tab)

  01.10.2026

• Caltagirone: il Consiglio torna a riunirsi lunedì 5 ottobre (öffnet in neuem Tab)

  La Gazzetta del Calatino · 01.10.2026

• Emerald Clinical Trials Appoints Michael Stibilj as Chief Executive Officer to Lead Next Phase of Global Growth (öffnet in neuem Tab)

  01.10.2026

• Mps, Lovaglio: «Delfin e Caltagirone riconosceranno il valore del piano» (öffnet in neuem Tab)

  ItalyPost · 30.09.2026

• Drug Repurposing Market - Global Strategic Business Report: Forecasts Growth to $37.3Billion by 2030, Profiling AbbVie, AstraZeneca, Pfizer, Novartis & Johnson & Johnson (öffnet in neuem Tab)

  30.09.2026

• MPS, Lovaglio punta sul sostegno di Delfin e Caltagirone per le offerte (öffnet in neuem Tab)

  Borsa Italiana · 30.09.2026

• Mps-Generali, Lovaglio apre a un intervento di Unicredit: È un’opzione. E confida nell’appoggio di Delfin e Caltagirone (öffnet in neuem Tab)

  Milano Finanza · 30.09.2026

• CAR T-Cell Therapy Market Forecasts Growth from $7.24B (2026) to $13.78B by 2031, Profiling Bristol-Myers Squibb, Gilead Sciences, Novartis & J&J (öffnet in neuem Tab)

  30.09.2026

• Caltagirone, da giovedì a domenica il “Viva Mexico Festival”: cibo, intrattenimento e laboratori (öffnet in neuem Tab)

  edacommunication.it · 30.09.2026

• Mpa su Rendiconto: "Serve una direzione per Caltagirone" (öffnet in neuem Tab)

  La Gazzetta del Calatino · 30.09.2026

• Schweizer Electronic AG Transitions to the Scale Segment of the Frankfurt Stock Exchange (öffnet in neuem Tab)

  29.09.2026

• Caltagirone, rara sindrome iperinfiammatoria in una bambina di 10 anni: diagnosi e trattamento tempestivi (öffnet in neuem Tab)

  NewSicilia · 29.09.2026

• Caltagirone, diagnosi tempestiva salva bimba da rara sindrome (öffnet in neuem Tab)

  La Gazzetta del Calatino · 29.09.2026

• Caltagirone, il consiglio boccia il rendiconto 2025: ora decide il commissario regionale (öffnet in neuem Tab)

  CataniaToday · 29.09.2026

• CAS announces collaboration with Novartis to advance AI-ready reaction informatics (öffnet in neuem Tab)

  29.09.2026